Table 2.
Long PFS group |
Short PFS group |
P |
|||
---|---|---|---|---|---|
No. | Percent (%) | No. | Percent (%) | ||
21L858R | 25 | 61% | 18 | 60% | 1·000 |
19 Del | 17 | 41% | 13 | 43% | 1·000 |
Del746–750 | 14 | 82% | 7 | 54% | 0·121 |
Complex EGFR mutations | 9 | 22% | 13 | 43% | 0·071 |
T790M mutation | 4 | 10% | 8 | 27% | 0·106 |
Co-occurring driver gene mutation | 4 | 10% | 10 | 33% | 0·018 |
Number of mutations | 7.63 ± 0.50 | 8·43 ± 0·65 | 0·314 | ||
EGFR pathway related mutations | 1.51 ± 0.19 | 1·37 ± 0·18 | 0·652 | ||
Non EGFR pathway mutations | 4.83 ± 0.41 | 5·57 ± 0·59 | 0·337 | ||
TP 53 mutations | 22 | 54% | 20 | 67% | 0·332 |
TP53 missense mutation | 11 | 27% | 14 | 47% | 0·131 |
RB1 mutations | 5 | 12% | 5 | 16% | 0·733 |
PIK3CA missense mutation | 0 | – | 3 | 10% | 0·071 |
MAP2K2 | 6 | 15% | 0 | – | 0·036 |
EGFR amplification | 6 | 15% | 7 | 23% | 0·371 |
BIM polymorphism | 4 | 10% | 4 | 13% | 0·714 |